title: Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix.
abstract: Because there is no consensus regarding the precise distribution of induced endothelial tissue factor (TF), we studied TF activity in and on tumor necrosis factor alpha-stimulated cultured human umbilical vein endothelial cells (ECs) and their underlying matrix. TF was mainly expressed on the cell surface. Only small traces were found on the apical surface suggesting that TF is predominantly located on the basolateral side of the cell membrane. The presence of TF on the cell surface was confirmed by flow cytometry. Subendothelial TF activity appeared to be dependent upon the procedure used to remove the stimulated EC monolayer. Whereas ammonium hydroxide or hypotonic lysis resulted in relatively high levels of matrix-associated TF, virtually no TF was found on the matrix after mild enzymatic detachment of stimulated ECs. Cell removal with EDTA resulted in intermediate levels of matrix-associated TF. Neither the enzymatic treatment nor EDTA degraded or removed this TF activity. Similar patterns were observed for matrix-associated TF antigen and EC surface markers. Electron microscopic analysis showed cell fragments on the matrix after monolayer lysis. The findings strongly suggest that induced endothelial TF associated with the subendothelial matrix actually represents TF on EC remnants.
authors.affiliation: Division of Haemostasis, University Hospital, Groningen, The Netherlands.
authors.forename: A B
authors.initials: AB
authors.lastname: Mulder
authors.forename: K S
authors.initials: KS
authors.lastname: Hegge-Paping
authors.forename: C P
authors.initials: CP
authors.lastname: Magielse
authors.forename: N R
authors.initials: NR
authors.lastname: Blom
authors.forename: J W
authors.initials: JW
authors.lastname: Smit
authors.forename: J
authors.initials: J
authors.lastname: van der Meer
authors.forename: M R
authors.initials: MR
authors.lastname: Hallie
authors.forename: V J
authors.initials: VJ
authors.lastname: Bom
mesh_terms: D000911:Antibodies, Monoclonal; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D005109:Extracellular Matrix / Q000378:metabolism / Q000648:ultrastructure; D015951:Factor Xa / Q000032:analysis / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D007118:Immunoassay; D007074:Immunoglobulin G; D008854:Microscopy, Electron; D012680:Sensitivity and Specificity; D013925:Thromboplastin / Q000096:biosynthesis / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014471:Umbilical Veins
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D014409:Tumor Necrosis Factor-alpha; D013925:Thromboplastin; D015951:Factor Xa